Literature DB >> 22327950

Psychiatric disease and drug abuse.

Karen Santucci1.   

Abstract

PURPOSE OF REVIEW: The term 'dual diagnosis' most commonly refers to the combination of severe mental illness and substance-use disorder (SUD). It is estimated that 7-10 million people in the USA alone have at a minimum one psychiatric disorder in addition to a SUD. As many of the psychiatric illnesses implicated have their origins in childhood, the pediatric population is not immune to this 'dual diagnosis', particularly with the increasing availability of street drugs and increasing accessibility to prescription drugs. The purpose of this review is to identify the magnitude of the problem and strengthen awareness among pediatric healthcare professionals who may provide prevention and/or early intervention. RECENT
FINDINGS: Causes for the dual diagnosis are unknown, but there are four hypotheses: common factors (risk factors common to both disorders), secondary mental disorder (substance use precipitates mental disorder), secondary substance use ('self-medication hypothesis') and bidirectional (presence of either mental illness or SUD can contribute to the development of the other).
SUMMARY: Those with the presence of this dual diagnosis are more likely to be nonadherent to treatment and may well have poorer outcomes. Integrated care for the maladies rather than split or isolated care is recommended. Psychosocial therapy holds promise for treating patients with dual diagnosis.

Entities:  

Mesh:

Year:  2012        PMID: 22327950     DOI: 10.1097/MOP.0b013e3283504fbf

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  12 in total

1.  Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.

Authors:  Katelijne van Emmerik-van Oortmerssen; Geurt van de Glind; Maarten W J Koeter; Steve Allsop; Marc Auriacombe; Csaba Barta; Eli Torild H Bu; Yuliya Burren; Pieter-Jan Carpentier; Susan Carruthers; Miguel Casas; Zsolt Demetrovics; Geert Dom; Stephen V Faraone; Melina Fatseas; Johan Franck; Brian Johnson; Máté Kapitány-Fövény; Sharlene Kaye; Maija Konstenius; Frances R Levin; Franz Moggi; Merete Møller; J Antoni Ramos-Quiroga; Arild Schillinger; Arvid Skutle; Sofie Verspreet; Wim van den Brink; Robert A Schoevers
Journal:  Addiction       Date:  2013-11-20       Impact factor: 6.526

2.  Utilizing social media to explore overdose and HIV/HCV risk behaviors among current opioid misusers.

Authors:  Patricia Cavazos-Rehg; Richard Grucza; Melissa J Krauss; Austin Smarsh; Nnenna Anako; Erin Kasson; Nina Kaiser; Samantha Sansone; Rachel Winograd; Laura J Bierut
Journal:  Drug Alcohol Depend       Date:  2019-10-28       Impact factor: 4.492

3.  Evaluating the resource allocation index as a potential fMRI-based biomarker for substance use disorder.

Authors:  Mahdi Moradi; Hamed Ekhtiari; Rayus Kuplicki; Brett McKinney; Jennifer L Stewart; Teresa A Victor; Martin P Paulus
Journal:  Drug Alcohol Depend       Date:  2020-08-09       Impact factor: 4.492

4.  Psychiatric comorbidity in adolescent use and poly-use of combustible, vaporized, and edible cannabis products.

Authors:  Adam M Leventhal; Dayoung Bae; Afton Kechter; Jessica L Barrington-Trimis
Journal:  J Psychiatr Res       Date:  2020-02-25       Impact factor: 4.791

5.  The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users.

Authors:  Barak Shapira; Paola Rosca; Ronny Berkovitz; Igor Gorjaltsan; Yehuda Neumark
Journal:  PeerJ       Date:  2020-07-17       Impact factor: 2.984

6.  Reward Processing in Novelty Seekers: A Transdiagnostic Psychiatric Imaging Biomarker.

Authors:  Shile Qi; Gunter Schumann; Juan Bustillo; Jessica A Turner; Rongtao Jiang; Dongmei Zhi; Zening Fu; Andrew R Mayer; Victor M Vergara; Rogers F Silva; Armin Iraji; Jiayu Chen; Eswar Damaraju; Xiaohong Ma; Xiao Yang; Michael Stevens; Daniel H Mathalon; Judith M Ford; James Voyvodic; Bryon A Mueller; Aysenil Belger; Steven G Potkin; Adrian Preda; Chuanjun Zhuo; Yong Xu; Congying Chu; Tobias Banaschewski; Gareth J Barker; Arun L W Bokde; Erin Burke Quinlan; Sylvane Desrivières; Herta Flor; Antoine Grigis; Hugh Garavan; Penny Gowland; Andreas Heinz; Jean-Luc Martinot; Marie-Laure Paillère Martinot; Eric Artiges; Frauke Nees; Dimitri Papadopoulos Orfanos; Tomáš Paus; Luise Poustka; Sarah Hohmann; Juliane H Fröhner; Michael N Smolka; Henrik Walter; Robert Whelan; Vince D Calhoun; Jing Sui
Journal:  Biol Psychiatry       Date:  2021-01-30       Impact factor: 12.810

7.  A questions-based investigation of consumer mental-health information.

Authors:  Colleen E Crangle; Joyce Brothers Kart
Journal:  PeerJ       Date:  2015-03-31       Impact factor: 2.984

8.  Structural brain characteristics of anabolic-androgenic steroid dependence in men.

Authors:  Lisa E Hauger; Lars T Westlye; Anders M Fjell; Kristine B Walhovd; Astrid Bjørnebekk
Journal:  Addiction       Date:  2019-05-15       Impact factor: 6.526

9.  Symptomatological Variants and Related Clinical Features in Adult Attention Deficit Hyperactive Disorder.

Authors:  Alessandro Pallucchini; Marco Carli; Marco Scarselli; Icro Maremmani; Giulio Perugi
Journal:  Int J Environ Res Public Health       Date:  2021-01-21       Impact factor: 3.390

Review 10.  Concurrent Disorder Management Guidelines. Systematic Review.

Authors:  Syune Hakobyan; Sara Vazirian; Stephen Lee-Cheong; Michael Krausz; William G Honer; Christian G Schutz
Journal:  J Clin Med       Date:  2020-07-28       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.